- Home
- CIVB vs CSTL Comparison
CIVB vs CSTL Comparison
Compare CIVB & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVB
- CSTL
- Stock Information
- Founded
- CIVB 1884
- CSTL 2007
- Country
- CIVB United States
- CSTL United States
- Employees
- CIVB N/A
- CSTL N/A
- Industry
- CIVB Major Banks
- CSTL Medical Specialities
- Sector
- CIVB Finance
- CSTL Health Care
- Exchange
- CIVB Nasdaq
- CSTL Nasdaq
- Market Cap
- CIVB 466.9M
- CSTL 555.8M
- IPO Year
- CIVB N/A
- CSTL 2019
- Fundamental
- Price
- CIVB $20.01
- CSTL $20.09
- Analyst Decision
- CIVB Buy
- CSTL Strong Buy
- Analyst Count
- CIVB 5
- CSTL 6
- Target Price
- CIVB $25.50
- CSTL $37.67
- AVG Volume (30 Days)
- CIVB 106.5K
- CSTL 682.4K
- Earning Date
- CIVB 07-24-2025
- CSTL 08-04-2025
- Dividend Yield
- CIVB 3.40%
- CSTL N/A
- EPS Growth
- CIVB 18.46
- CSTL N/A
- EPS
- CIVB 2.52
- CSTL N/A
- Revenue
- CIVB $157,428,000.00
- CSTL $346,269,000.00
- Revenue This Year
- CIVB $17.31
- CSTL N/A
- Revenue Next Year
- CIVB $9.98
- CSTL $1.62
- P/E Ratio
- CIVB $7.93
- CSTL N/A
- Revenue Growth
- CIVB 7.00
- CSTL 20.40
- 52 Week Low
- CIVB $15.85
- CSTL $14.59
- 52 Week High
- CIVB $25.59
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CIVB 42.29
- CSTL 62.20
- Support Level
- CIVB $19.01
- CSTL $18.99
- Resistance Level
- CIVB $20.98
- CSTL $20.18
- Average True Range (ATR)
- CIVB 0.49
- CSTL 0.95
- MACD
- CIVB 0.16
- CSTL 0.37
- Stochastic Oscillator
- CIVB 52.22
- CSTL 81.57
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.